Robson W L, Leung A K
Division of Pediatric Nephrology, Children's Hospital, Calgary, Alberta, Canada.
J Natl Med Assoc. 1994 Oct;86(10):775-8.
A literature search revealed 23 studies that have reported on the type or frequency of side effects or complications associated with the use of desmopressin (DDAVP, Rhône-Poulenc Rorer Pharmaceuticals Inc, Collegeville, Pennsylvania) for the treatment of enuresis. Thirty-one (4.3%) side effects were reported in 717 patients. Seizure secondary to water intoxication is a potential complication of treatment with desmopressin and was reported in six patients, usually in association with excess fluid intake during the evening or day preceding the use of desmopressin. Desmopressin appears to have a favorable safety profile. Patients should be specifically instructed not to ingest excess fluids during the evening prior to administration of desmopressin.
一项文献检索发现,有23项研究报告了与使用去氨加压素(DDAVP,罗纳普朗克·罗雷尔制药公司,宾夕法尼亚州学院镇)治疗遗尿症相关的副作用或并发症的类型或频率。717名患者报告了31例(4.3%)副作用。水中毒继发癫痫是去氨加压素治疗的潜在并发症,有6例患者报告了该并发症,通常与在使用去氨加压素前一晚或当天过量摄入液体有关。去氨加压素似乎具有良好的安全性。应特别指示患者在服用去氨加压素前一晚不要摄入过多液体。